#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biotinidase deficiency Langerhans' cell histiocytosis Acute graft versus host disease in liver Hereditary optic atrophy Idiopathic inflammatory myopathy Depression Renal cell carcinoma Hypocalcaemia Neurofibroma Angelman's syndrome Anti-glomerular basement membrane disease Wiskott-Aldrich syndrome Sickle cell anaemia Chronic lymphocytic leukaemia Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Basic Information Leiomyosarcoma metastatic Metachromatic leukodystrophy – Life with Disease Uterine leiomyosarcoma – Treatment Lymphangioma Cerebral arteriovenous malformation haemorrhagic – Treatment Retinitis pigmentosa – Basic Information Erdheim-Chester disease – Treatment Ornithine transcarbamoylase deficiency – Diagnostics Alagille syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Art6043 Oxcarbazepine Syn2 Ide397 Atropine Sulfate IMB 101 ABY-271 Venlafaxine Hydrochloride Sodium Iodide (123 I) Dexamethasone Ph. Eur. Izaflortaucipir (18F) Elamipretide Trihydrochloride Ribonucleic Acid K30 Montelukast Pristinamycin Potassium Oxybate Other Immunosuppressants Perindopril Arginine Trifluridine Autologous Microfat More therapies…

    Learn about Your Condition

    Cervix carcinoma stage III Appendicitis perforated Uterine cancer Respiratory tract infection Anaemia of pregnancy Mite allergy Pelizaeus-Merzbacher disease Hepatorenal syndrome Albright's disease Endocarditis bacterial Colorectal adenoma Intestinal obstruction Inguinal hernia Alcohol use disorder Chorea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread

    Recruiting

    3 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Darovasertib
    Austria Belgium Czechia Denmark France Germany +4

  • A Phase 2 Study of Aganirsen Eye Drops to Extend Intravitreal Aflibercept Injection Interval in Patients with Wet Age‑Related Macular Degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • AGANIRSEN
    • Aflibercept
    France

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    • Dry age-related macular degeneration
    France

  • Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Phenylephrine Hydrochloride
    • Dexmedetomidine
    • Oxybuprocaine Hydrochloride
    Norway

  • A study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Belgium Italy The Netherlands Norway

  • A study comparing the effectiveness of brimonidine tartrate and timolol eye drops versus a standard combination in patients with glaucoma or ocular hypertension

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Timolol
    • Timolol Maleate
    • Brimonidine Tartrate
    Greece
Previous Page
1 … 11 12 13 14 15 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!